Respiratory disease and the oesophagus: Reflux, reflexes and microaspiration

Nature Reviews Gastroenterology and Hepatology

Volumn 13, Issue 8, 2016, Pages 445-460

  Houghton, Lesley A ^a,b   Lee, Augustine S ^a   Badri, Huda ^b   Devault, Kenneth R ^a   Smith, Jaclyn A ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BILE SALT; GABAPENTIN; GASTRICSIN; OPIATE; PEPSIN A; PREGABALIN; PROTON PUMP INHIBITOR; SALBUTAMOL; THEOPHYLLINE; RESPIRATORY TRACT AGENT;

ABDOMINAL PRESSURE; ACID ASPIRATION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DRUG SAFETY; DYSPNEA; ESOPHAGEAL PH MONITORING; ESOPHAGUS MOTILITY; ESOPHAGUS MUCOSA; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERINFLATION; LARYNGOPHARYNGEAL REFLUX; LOWER ESOPHAGUS SPHINCTER; LUNG COMPLIANCE; METHODOLOGY; MICROASPIRATION; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PERMEABILITY BARRIER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SMOKING; STOMACH EMPTYING; STOMACH FUNDOPLICATION; STOMACH MOTILITY; UPPER ESOPHAGUS SPHINCTER; WHEEZING; ADVERSE EFFECTS; BREATHING DISORDER; BRONCHUS; COMPLICATION; ESOPHAGUS; GASTROINTESTINAL MOTILITY; INNERVATION; LUNG DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; PNEUMONIA, ASPIRATION; RESPIRATORY SOUNDS; STOMACH;

ANTACIDS; BRONCHI; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HUMANS; LUNG DISEASES; PNEUMONIA, ASPIRATION; RESPIRATION DISORDERS; RESPIRATORY SOUNDS; RESPIRATORY SYSTEM AGENTS; SMOKING; STOMACH;

EID: 84977139577     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2016.91     Document Type: Review

References (189)

1. Francis D. O, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am. J. Gastroenterol. 108, 905-911 (2013).
2. Allaix M. E, et al. Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment. J. Gastrointest. Surg. 18, 100-104; discussion 104-105 (2014).
3. Blondeau K, Dupont L. J, Mertens V, Tack J, & Sifrim D. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough. Aliment. Pharmacol. Ther. 25, 723-732 (2007).
4. Blondeau K, et al. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 57, 1049-1055 (2008).
5. Blondeau K, et al. The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH manometry recordings. Pediatr. Pulmonol. 46, 286-294 (2011).
6. Button B. M, et al. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J. Heart Lung Heart Transplant. 24, 1522-1529 (2005).
7. Campo S, et al. Esophageal dysmotility and gastroesophageal reflux in intrinsic asthma. Dig. Dis. Sci. 42, 1184-1188 (1997).
8. Casanova C, et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur. Respir. J. 23, 841-845 (2004).
9. DiMarco A. F, Kelsen S. G, Cherniack N. S, & Gothe B. Occlusion pressure and breathing pattern in patients with interstitial lung disease. Am. Rev. Respir. Dis. 127, 425-430 (1983).
10. D'Ovidio F, et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann. Thorac. Surg. 80, 1254-1260 (2005).
11. Gao F, et al. The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis. BMC Gastroenterol. 15, 26 (2015).
12. Gastal O. L, Castell J. A, & Castell D. O. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring. Chest 106, 1793-1796 (1994).
13. Harding S. M, Guzzo M. R, & Richter J. E. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am. J. Respir. Crit. Care Med. 162, 34-39 (2000).
14. Heine R. G, Button B. M, Olinsky A, Phelan P. D, & Catto-Smith A. G. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch. Dis. Child. 78, 44-48 (1998).
15. Hoppo T, Komatsu Y, & Jobe B. A. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance. Dis. Esophagus 27, 530-537 (2014).
16. Kamble N. L, Khan N. A, Kumar N, Nayak H. K, & Daga M. K. Study of gastro-oesophageal reflux disease in patients with mild to moderate chronic obstructive pulmonary disease in India. Respirology 18, 463-467 (2013).
17. Kastelik J. A, et al. Abnormal oesophageal motility in patients with chronic cough. Thorax 58, 699-702 (2003).
18. Kempainen R. R, et al. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest 131, 1666-1671 (2007).
19. Kilduff C. E, Counter M. J, Thomas G. A, Harrison N. K, & Hope-Gill B. D. Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study. Cough 10, 4 (2014).
20. Kiljander T. O, & Laitinen J. O. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 126, 1490-1494 (2004).
21. Kiljander T. O, Salomaa E. R, Hietanen E. K, & Terho E. O. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest 116, 1257-1264 (1999).
22. Kiljander T. O, Salomaa E. R, Hietanen E. K, & Terho E. O. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur. Respir. J. 16, 633-638 (2000).
23. Leggett J. J, Johnston B. T, Mills M, Gamble J, & Heaney L. G. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest 127, 1227-1231 (2005).
24. Mastronarde J. G, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N. Engl. J. Med. 360, 1487-1499 (2009).
25. Patti M. G, et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic?. J. Gastrointest. Surg. 9, 1053-1056; discussion 1056-1058 (2005).
26. Pauwels A, et al. Gastric emptying and different types of reflux in adult patients with cystic fibrosis. Aliment. Pharmacol. Ther. 34, 799-807 (2011).
27. Raghu G, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur. Respir. J. 27, 136-142 (2006).
28. Ribolsi M, et al. Reflux pattern and role of impedance pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment. Pharmacol. Ther. 40, 966-973 (2014).
29. Salvioli B, et al. Gastro-oesophageal reflux and interstitial lung disease. Dig. Liver Dis. 38, 879-884 (2006).
30. Savarino E, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur. Respir. J. 42, 1322-1331 (2013).
31. Schnatz P. F, Castell J. A, & Castell D. O. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am. J. Gastroenterol. 91, 1715-1718 (1996).
32. Sifrim D, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 54, 449-454 (2005).
33. Smith J. A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 139, 754-762 (2010).
34. Sweet M. P, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J. Thorac. Cardiovasc. Surg. 133, 1078-1084 (2007).
35. Tobin R. W, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 158, 1804-1808 (1998).
36. Wong C. H, Chua C. J, Liam C. K, & Goh K. L. Gastro-oesophageal reflux disease in 'difficult-To control' asthma: prevalence and response to treatment with acid suppressive therapy. Aliment. Pharmacol. Ther. 23, 1321-1327 (2006).
37. Mendelson C. L. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am. J. Obstet. Gynecol. 52, 191-205 (1946).
38. Petty T. L, & Ashbaugh D. G. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest 60, 233-239 (1971).
39. Gajic O, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am. J. Respir. Crit. Care Med. 183, 462-470 (2011).
40. Lee A, et al. Characteristics and outcomes of patients hospitalized following pulmonary aspiration. Chest 146, 899-907 (2014).
41. Babaei A, et al. Response of the upper esophageal sphincter to esophageal distension is affected by posture, velocity, volume, and composition of the infusate. Gastroenterology 142, 734-743.e7 (2012).
42. Bajaj J. S, et al. Influence of sleep stages on esophago-upper esophageal sphincter contractile reflex and secondary esophageal peristalsis. Gastroenterology 130, 17-25 (2006).
43. Dua K, Surapaneni S. N, Kuribayashi S, Hafeezullah M, & Shaker R. Pharyngeal airway protective reflexes are triggered before the maximum volume of fluid that the hypopharynx can safely hold is exceeded. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G197-G202 (2011).
44. Phua S. Y, McGarvey L. P, Ngu M. C, & Ing A. J. Patients with gastro-oesophageal reflux disease and cough have impaired laryngopharyngeal mechanosensitivity. Thorax 60, 488-491 (2005).
45. Phua S. Y, McGarvey L, Ngu M, & Ing A. The differential effect of gastroesophageal reflux disease on mechanostimulation and chemostimulation of the laryngopharynx. Chest 138, 1180-1185 (2010).
46. Mendell D. A, & Logemann J. A. A retrospective analysis of the pharyngeal swallow in patients with a clinical diagnosis of GERD compared with normal controls: a pilot study. Dysphagia 17 220-226 (2002).
47. Setzen M, et al. The association between laryngopharyngeal sensory deficits, pharyngeal motor function, and the prevalence of aspiration with thin liquids. Otolaryngol. Head Neck Surg. 128, 99-102 (2003).
48. Clayton N. A, Carnaby-Mann G. D, Peters M. J, & Ing A. J. The effect of chronic obstructive pulmonary disease on laryngopharyngeal sensitivity. Ear Nose Throat J. 91, 370-382 (2012).
49. Clayton N. A, Carnaby G. D, Peters M. J, & Ing A. J. Impaired laryngopharyngeal sensitivity in patients with COPD: the association with swallow function. Int. J. Speech Lang. Pathol. 16, 615-623 (2014).
50. Cassiani R. A, Santos C. M, Baddini-Martinez J, & Dantas R. O. Oral and pharyngeal bolus transit in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 489-496 (2015).
51. Bautista T. G, Sun Q. J, & Pilowsky P. M. The generation of pharyngeal phase of swallow and its coordination with breathing: interaction between the swallow and respiratory central pattern generators. Prog. Brain Res. 212, 253-275 (2014).
52. Wheeler Hegland K. M, Huber J. E, Pitts T, & Sapienza C. M. Lung volume during swallowing: single bolus swallows in healthy young adults. J. Speech Lang. Hear. Res. 52, 178-187 (2009).
53. Smith J. A, et al. Chest wall dynamics during voluntary and induced cough in healthy volunteers. J. Physiol. 590, 563-574 (2012).
54. Shaker R, et al. Coordination of deglutition and phases of respiration: effect of aging, tachypnea, bolus volume, and chronic obstructive pulmonary disease. Am. J. Physiol. 263, G750-G755 (1992).
55. Cvejic L, et al. Laryngeal penetration and aspiration in individuals with stable COPD. Respirology 16, 269-275 (2011).
56. Trioathi A, Mirant-Borde M. C, & Lee A. Amylase in broncho-Alveolar lavage as a potential marker of oropharyngeal-To pulmonary aspiration. Am. J. Respir. Crit. Care Med. 183, A4616 (2011).
57. Rennard S. I, et al. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am. Rev. Respir. Dis. 141, 208-217 (1990).
58. Trinick R, Johnston N, Dalzell A. M, & McNamara P. S. Reflux aspiration in children with neurodisability - A significant problem, but can we measure it?. J. Pediatr. Surg. 47, 291-298 (2012).
59. Knight J, Lively M. O, Johnston N, Dettmar P. W, & Koufman J. A. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 115, 1473-1478 (2005).
60. Parikh S, et al. Are the enzymatic methods currently being used to measure bronchoalveolar lavage bile salt levels fit for purpose?. J. Heart Lung Transplant. 32, 418-423 (2013).
61. Bohman J. K, et al. Airway pepsin levels in otherwise healthy surgical patients receiving general anesthesia with endotracheal intubation. Chest 143, 1407-1413 (2013).
62. Gerson K. D, et al. Pepsinogen C proteolytic processing of surfactant protein B. J. Biol. Chem. 283, 10330-10338 (2008).
63. McNally P, et al. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin 8 concentrations. Thorax 66, 140-143 (2011).
64. Lee J. S, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur. Respir. J. 39, 352-358 (2012).
65. Pauwels A, et al. Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest 141, 1568-1574 (2012).
66. Lee A. L, et al. Exhaled breath condensate pepsin: potential noninvasive test for gastroesophageal reflux in COPD and bronchiectasis. Respir. Care 60, 244-250 (2015).
67. Perng D. W, et al. Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor β1 production and fibroblast proliferation. Chest 132, 1548-1556 (2007).
68. Timms C, Thomas P. S, & Yates D. H. Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling. J. Breath Res. 6, 016003 (2012).
69. Blondeau K, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur. Respir. J. 31, 707-713 (2008).
70. Decalmer S, et al. Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency. Chest 142, 958-964 (2012).
71. Grabowski M, et al. Pepsin and bile acids in induced sputum of chronic cough patients. Respir. Med. 105, 1257-1261 (2011).
72. Amaris M, Dua K. S, Naini S. R, Samuel E, & Shaker R. Characterization of the upper esophageal sphincter response during cough. Chest 142, 1229-1236 (2012).
73. Pauwels A, et al. The effect of gastric juice on interleukin 8 production by cystic fibrosis primary bronchial epithelial cells. J. Cyst. Fibros. 12, 700-705 (2013).
74. Dimango E, et al. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. BMC Pulm. Med. 14, 21 (2014).
75. Herzig S. J, Howell M. D, Ngo L. H, & Marcantonio E. R. Acid-suppressive medication use and the risk for hospital-Acquired pneumonia. JAMA 301, 2120-2128 (2009).
76. Sarkar M, Hennessy S, & Yang Y. X. Proton-pump inhibitor use and the risk for community-Acquired pneumonia. Ann. Intern. Med. 149, 391-398 (2008).
77. Kreuter M, et al. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir. Med. 4, 381-389 (2016).
78. Gray S. L, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch. Intern. Med. 170, 765-771 (2010).
79. Gomm W, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol. 73, 410-416 (2016).
80. Lazarus B, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern. Med. 176, 238-246 (2016).
81. Jackson M. A, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 65, 749-756 (2015).
82. Howell M. D, et al. Latrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch. Intern. Med. 170, 784-790 (2010).
83. de Bortoli N, et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?. World J. Gastroenterol. 18, 4363-4370 (2012).
84. Branski R. C, Bhattacharyya N, & Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 112, 1019-1024 (2002).
85. Kelchner L. N, et al. Reliability of speech-language pathologist and otolaryngologist ratings of laryngeal signs of reflux in an asymptomatic population using the reflux finding score. J. Voice 21, 92-100 (2007).
86. Musser J, Kelchner L, Neils-Strunjas J, & Montrose M. A comparison of rating scales used in the diagnosis of extraesophageal reflux. J. Voice 25 293-300 (2011).
87. Ummarino D, et al. Gastroesophageal reflux evaluation in patients affected by chronic cough: restech versus multichannel intraluminal impedance/.pH metry. Laryngoscope 123, 980-984 (2013).
88. Zerbib F, et al. Normal values of pharyngeal and esophageal 24 hour pH impedance in individuals on and off therapy and interobserver reproducibility. Clin. Gastroenterol. Hepatol. 11, 366-372 (2013).
89. Kawamura O, et al. Increase of weakly acidic gas esophagopharyngeal reflux (EPR) and swallowing-induced acidic/weakly acidic EPR in patients with chronic cough responding to proton pump inhibitors. Neurogastroenterol. Motil. 23, 411-e172 (2011).
90. Patterson N, et al. Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J. Clin. Gastroenterol. 43, 414-419 (2009).
91. Komatsu Y, Hoppo T, & Jobe B. A. Proximal reflux as a cause of adult-onset asthma: the case for hypopharyngeal impedance testing to improve the sensitivity of diagnosis. JAMA Surg. 148, 50-58 (2013).
92. Banaszkiewicz A, et al. Evaluation of laryngopharyngeal reflux in pediatric patients with asthma using a new technique of pharyngeal pH monitoring. Adv. Exp. Med. Biol. 755, 89-95 (2013).
93. Kunsch S, et al. Combined lung-sound and reflux-monitoring: a pilot study of a novel approach to detect nocturnal respiratory symptoms in gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 33, 592-600 (2011).
94. Bogte A, Bredenoord A. J, & Smout A. J. Diagnostic yield of oesophageal pH monitoring in patients with chronic unexplained cough. Scand. J. Gastroenterol. 43, 13-19 (2008).
95. Avidan B, Sonnenberg A, Schnell T. G, & Sontag S. J. Temporal associations between coughing or wheezing and acid reflux in asthmatics. Gut 49, 767-772 (2001).
96. Paterson W. G, & Murat B. W. Combined ambulatory esophageal manometry and dual-probe pH metry in evaluation of patients with chronic unexplained cough. Dig. Dis. Sci. 39, 1117-1125 (1994).
97. Kelsall A, et al. How to quantify coughing: correlations with quality of life in chronic cough. Eur. Respir. J. 32, 175-179 (2008).
98. Decalmer S, Kelsall A, & McGuiness K. Patient registering of coughevents during 24 hour oesophageal impedance monitoring. Am. J. Respir. Crit. Care Med. 175, A380 (2007).
99. Kelsall A, Decalmer S, McGuinness K, Woodcock A, & Smith J. A. Sex differences and predictors of objective cough frequency in chronic cough. Thorax 64, 393-398 (2009).
100. Kavitt R. T, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am. J. Gastroenterol. 107, 1826-1832 (2012).
101. Wiener G. J, Richter J. E, Copper J. B, Wu W. C, & Castell D. O. The symptom index: a clinically important parameter of ambulatory 24 hour esophageal pH monitoring. Am. J. Gastroenterol. 83, 358-361 (1988).
102. Breumelhof R, & Smout A. J. The symptom sensitivity index: a valuable additional parameter in 24 hour esophageal pH recording. Am. J. Gastroenterol. 86, 160-164 (1991).
103. Weusten B. L, Roelofs J. M, Akkermans L. M, Van Berge-Henegouwen G. P, & Smout A. J. The symptom-Association probability: an improved method for symptom analysis of 24 hour esophageal pH data. Gastroenterology 107, 1741-1745 (1994).
104. Reid L. in Ciba Foundation symposium: Development of the Lung (eds DeRuck A. V. S, & Porter R.) 109-124 (Little, 1967).
105. Ing A. J, Ngu M. C, & Breslin A. B. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am. J. Respir. Crit. Care Med. 149, 160-167 (1994).
106. Javorkova N, et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol. Motil. 20, 119-124 (2008).
107. Herve P, Denjean A, Jian R, Simonneau G, & Duroux P. Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am. Rev. Respir. Dis. 134, 986-989 (1986).
108. Araujo A. C, Aprile L. R, Dantas R. O, Terra Filho J, & Vianna E. O. Bronchial responsiveness during esophageal acid infusion. Lung 186, 123-128 (2008).
109. Field S. K. A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adults. Chest 115 848-856 (1999).
110. Andersen L. I, Schmidt A, & Bundgaard A. Pulmonary function and acid application in the esophagus. Chest 90, 358-363 (1986).
111. Wu D. N, et al. Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bronchial asthma. Chest 118, 1553-1556 (2000).
112. Wu D. N, et al. Effects of esophageal acid perfusion on cough responsiveness in patients with bronchial asthma. Chest 122, 505-509 (2002).
113. Ekstrom T, & Tibbling L. Esophageal acid perfusion, airway function, and symptoms in asthmatic patients with marked bronchial hyperreactivity. Chest 96, 995-998 (1989).
114. Irwin R. S, French C. L, Curley F. J, Zawacki J. K, & Bennett F. M. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 104, 1511-1517 (1993).
115. Orr W. C, Shamma-Othman Z, Allen M, & Robinson M. G. Esophageal function and gastroesophageal reflux during sleep and waking in patients with chronic obstructive pulmonary disease. Chest 101, 1521-1525 (1992).
116. Ducolone A, et al. Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am. Rev. Respir. Dis. 135, 327-332 (1987).
117. Kessing B. F, et al. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am. J. Gastroenterol. 106, 2093-2097 (2011).
118. Farre R, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut 60, 885-892 (2011).
119. Woodland P, et al. Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G525-G531 (2015).
120. Farre R, et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 57, 1366-1374 (2008).
121. Woodland P, Al Zinaty M, Yazaki E, & Sifrim D. In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut 62, 1256-1261 (2013).
122. Borrelli O, et al. Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 39, 733-742 (2014).
123. Fouad Y. M, Katz P. O, Hatlebakk J. G, & Castell D. O. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-Associated respiratory symptoms. Am. J. Gastroenterol. 94, 1464-1467 (1999).
124. Bandeira C. D, Rubin A. S, Cardoso P. F, Moreira Jda S, & Machado Mda M. Prevalence of gastroesophageal reflux disease in patients with idiopathic pulmonary fibrosis. J. Bras. Pneumol. 35, 1182-1189 (in Portuguese) (2009).
125. Soares R. V, et al. Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment. Arq. Gastroenterol. 48, 91-97 (2011).
126. Almansa C, et al. Weak peristalsis with large breaks in chronic cough: association with poor esophageal clearance. Neurogastroenterol. Motil. 27, 431-442 (2015).
127. Vardar R, Sweis R, Anggiansah A, Wong T, & Fox M. R. Upper esophageal sphincter and esophageal motility in patients with chronic cough and reflux: assessment by high-resolution manometry. Dis. Esophagus 26, 219-225 (2013).
128. Chaiteerakij R, Wongrim S, & Gonlachanvit S. Association between bronchial hyperresponsiveness (Bhr) and esophageal dysmotility (ED) in patients who were suspected of gastroesophageal reflux disease (GERD). Gastroenterology 134, A726 (2008).
129. Dent J, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J. Clin. Invest. 65, 256-267 (1980).
130. Mittal R. K, & McCallum R. W. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 95, 593-599 (1988).
131. Mittal R. K, & Fisher M. J. Electrical and mechanical inhibition of the crural diaphragm during transient relaxation of the lower esophageal sphincter. Gastroenterology 99, 1265-1268 (1990).
132. Mittal R. K, Rochester D. F, & McCallum R. W. Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans. Am. J. Physiol. 256, G139-G144 (1989).
133. Mittal R. K, Sivri B, Schirmer B. D, & Heine K. J. Effect of crural myotomy on the incidence and mechanism of gastroesophageal reflux in cats. Gastroenterology 105, 740-747 (1993).
134. Carvalho de Miranda Chaves R, Suesada M, Polisel F, de Sa C. C, & Navarro-Rodriguez T. Respiratory physiotherapy can increase lower esophageal sphincter pressure in GERD patients. Respir. Med. 106, 1794-1799 (2012).
135. Nobre e Souza M. A, et al. Inspiratory muscle training improves antireflux barrier in GERD patients. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G862-G867 (2013).
136. Scheffer R. C, Gooszen H. G, Hebbard G. S, & Samsom M. The role of transsphincteric pressure and proximal gastric volume in acid reflux before and after fundoplication. Gastroenterology 129, 1900-1909 (2005).
137. Frankhuisen R, et al. Increased intragastric pressure gradients are involved in the occurrence of acid reflux in gastroesophageal reflux disease. Scand. J. Gastroenterol. 44, 545-550 (2009).
138. Sifrim D, & Holloway R. Transient lower esophageal sphincter relaxations: how many or how harmful?. Am. J. Gastroenterol. 96, 2529-2532 (2001).
139. Trudgill N. J, & Riley S. A. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am. J. Gastroenterol. 96, 2569-2574 (2001).
140. Pauwels A, Blondeau K, Dupont L. J, & Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am. J. Gastroenterol. 107, 1346-1353 (2012).
141. Zerbib F, et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am. J. Respir. Crit. Care Med. 166, 1206-1211 (2002).
142. Gadel A. A, Mostafa M, Younis A, & Haleem M. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology 59, 2498-2502 (2012).
143. Richter J. E. Delayed gastric emptying in reflux patients: to be or not to be?. Am. J. Gastroenterol. 92, 1077-1078 (1997).
144. Holloway R. H, Hongo M, Berger K, & McCallum R. W. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 89, 779-784 (1985).
145. Bodet-Milin C, et al. Delayed gastric emptying scintigraphy in cystic fibrosis patients before and after lung transplantation. J. Heart Lung Transplant. 25, 1077-1083 (2006).
146. Davis C. S, et al. Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation. J. Surg. Res. 185, e101-e108 (2013).
147. Cavell B. Gastric emptying in infants with cystic fibrosis. Acta Paediatr. Scand. 70, 635-638 (1981).
148. Amarasiri W. A, et al. Gastric motility following ingestion of a solid meal in a cohort of adult asthmatics. J. Neurogastroenterol. Motil. 19, 355-365 (2013).
149. Kastelik J. A, et al. Measurement of gastric emptying in gastroesophageal reflux-related chronic cough. Chest 122, 2038-2041 (2002).
150. Emerenziani S, et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am. J. Gastroenterol. 100, 1251-1256 (2005).
151. Liang B. M, & Feng Y. L. Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung 190, 277-282 (2012).
152. Gea J, Agusti A, & Roca J. Pathophysiology of muscle dysfunction in COPD. J. Appl. Physiol. (1985) 114, 1222-1234 (2013).
153. Ottenheijm C. A, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 172, 200-205 (2005).
154. Noth I, et al. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 39, 344-351 (2012).
155. Ayazi S, et al. Thoraco-Abdominal pressure gradients during the phases of respiration contribute to gastroesophageal reflux disease. Dig. Dis. Sci. 56, 1718-1722 (2011).
156. Montes de Oca M, Rassulo J, & Celli B. R. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am. J. Respir. Crit. Care Med. 154, 1284-1289 (1996).
157. Pandolfino J. E, Bianchi L. K, Lee T. J, Hirano I, & Kahrilas P. J. Esophagogastric junction morphology predicts susceptibility to exercise-induced reflux. Am. J. Gastroenterol. 99, 1430-1436 (2004).
158. Irvin C. G, Sampson M, Engel L, & Grassino A. E. Effect of breathing pattern on esophageal pressure gradients in humans. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 57, 168-175 (1984).
159. Mittal R. K, Shaffer H. A, Parollisi S, & Baggett L. Influence of breathing pattern on the esophagogastric junction pressure and esophageal transit. Am. J. Physiol. 269, G577-G583 (1995).
160. Penagini R, Schoeman M. N, Dent J, Tippett M. D, & Holloway R. H. Motor events underlying gastro oesophageal reflux in ambulant patients with reflux oesophagitis. Neurogastroenterol. Motil. 8, 131-141 (1996).
161. Schoeman M. N, Tippett M. D, Akkermans L. M, Dent J, & Holloway R. H. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 108, 83-91 (1995).
162. van Herwaarden M. A, Samsom M, & Smout A. J. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology 119, 1439-1446 (2000).
163. Kim J, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm. Med. 13, 51 (2013).
164. Sontag S. J, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 99, 613-620 (1990).
165. Schindlbeck N. E, Heinrich C, Huber R. M, & Muller-Lissner S. A. Effects of albuterol (salbutamol) on esophageal motility and gastroesophageal reflux in healthy volunteers. JAMA 260, 3156-3158 (1988).
166. Stein M. R, et al. The effect of theophylline on the lower esophageal sphincter pressure. Ann. Allergy 45, 238-241 (1980).
167. Berquist W. E, et al. Effect of theophylline on gastroesophageal reflux in normal adults. J. Allergy Clin. Immunol. 67, 407-411 (1981).
168. Johannesson N, Andersson K. E, Joelsson B, & Persson C. G. Relaxation of lower esophageal sphincter and stimulation of gastric secretion and diuresis by antiasthmatic xanthines. Role of adenosine antagonism. Am. Rev. Respir. Dis. 131, 26-30 (1985).
169. Crowell M. D, Zayat E. N, Lacy B. E, Schettler Duncan A, & Liu M. C. The effects of an inhaled β2-Adrenergic agonist on lower esophageal function: a dose-response study. Chest 120, 1184-1189 (2001).
170. Hongo M, Traube M, McAllister R. G. Jr & McCallum R. W. Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology 86, 8-12 (1984).
171. Becker B. S, & Burakoff R. The effect of verapamil on the lower esophageal sphincter pressure in normal subjects and in achalasia. Am. J. Gastroenterol. 78, 773-775 (1983).
172. Kadakia S. C, Kikendall J. W, Maydonovitch C, & Johnson L. F. Effect of cigarette smoking on gastroesophageal reflux measured by 24 h ambulatory esophageal pH monitoring. Am. J. Gastroenterol. 90, 1785-1790 (1995).
173. Kahrilas P. J. Cigarette smoking and gastroesophageal reflux disease. Dig. Dis. 10, 61-71 (1992).
174. Ours T. M, Kavuru M. S, Schilz R. J, & Richter J. E. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am. J. Gastroenterol. 94, 3131-3138 (1999).
175. Eherer A. J, et al. Effect of pantoprazole on the course of reflux-Associated laryngitis: a placebo-controlled double-blind crossover study. Scand. J. Gastroenterol. 38, 462-467 (2003).
176. Chang A. B, et al. Systematic review and meta-Analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. BMJ 332, 11-17 (2006).
177. Littner M. R, Leung F. W, Ballard E. D. 2nd, Huang B, & Samra N. K. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 128, 1128-1135 (2005).
178. Kiljander T. O, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am. J. Respir. Crit. Care Med. 173, 1091-1097 (2006).
179. Gibson P. G, Henry R. L, & Coughlan J. L. Gastro oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst. Rev. 2, CD001496 (2003).
180. Richter J. E. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin. Gastroenterol. Hepatol. 11, 465-471; quiz e39 (2013).
181. Morice A. H, et al. Opiate therapy in chronic cough. Am. J. Respir. Crit. Care Med. 175, 312-315 (2007).
182. Mintz S, & Lee J. K. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am. J. Med. 119, e13-e15 (2006).
183. Ryan N. M, Birring S. S, & Gibson P. G. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 380, 1583-1589 (2012).
184. Vertigan A. E, et al. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest 149, 639-648 (2016).
185. Abdulqawi R, et al. P2X3 receptor antagonist (AF 219) in refractory chronic cough: a randomised double-blind, placebo-controlled phase 2 study. Lancet 385, 1198-1205 (2015).
186. Vela M. F. Medical treatments of GERD: the old and new. Gastroenterol. Clin. North Am. 43, 121-133 (2014).
187. Ren L. H, et al. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta analysis. World J. Gastroenterol. 20, 2412-2419 (2014).
188. Halter F, Staub P, Hammer B, Guyot J, & Miazza B. M. Study with two prokinetics in functional dyspepsia and GORD: domperidone versus cisapride. J. Physiol. Pharmacol. 48, 185-192 (1997).
189. Shaker R, & Hogan W. J. Reflex-mediated enhancement of airway protective mechanisms. Am. J. Med. 108 (Suppl. 4a), 8S-14S (2000).